Please try another search
Volpara Health Technologies Limited provides breast imaging analytics software products in New Zealand. The company offers Volpara Analytics, a software that optimize breast cancer screening operations; Volpara Live, which provides instant patient-based image quality feedback; Volpara Lung, a patient management software that streamlines lung screening workflow; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses TC8 to calculate patients’ risk of developing breast cancer; Volpara Risk Pathways, a program for identifying and managing high-risk breast, lung, ovarian, and colorectal cancer screening patients; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products; and Volpara Thumbnail, an image-enhanced patient notification letters. In addition, the company provides TruDensity, a Volpara clinical function; TruPGMI, a Volpara clinical function, which uses artificial intelligence to automatically and objectively assess the positioning of the patient and resulting image quality; TruPressure, a Volpara clinical function, which determines whether the compression pressure applied by the radiographer is in the sweet spot that yields quality images, minimal radiation exposure, and the least discomfort; and TruRadDose, a Volpara clinical function which analyses the radiation dose delivered to patients based on their breast density. It operates in North America, the Asia Pacific, Europe, the Middle East, and Africa. Volpara Health Technologies Limited has a strategic relationship with RevealDx. The company was incorporated in 2009 and is headquartered in Wellington, New Zealand.
Name | Age | Since | Title |
---|---|---|---|
Mark Bouw | - | 2023 | Independent Non-Executive Director |
Paul Robert Thomas Reid | - | 2018 | Independent Non-Executive Chairman of the Board |
Teri Thomas | - | 2022 | CEO, MD & Director |
Martin Yaffe | - | - | Member of Scientific Board |
Gerard J. den Heeten | - | - | Member of Medical Advisory Board |
Roger W. Allen | 77 | 2010 | Non-Executive Director |
Jennifer Harvey | - | - | Member of Medical Advisory Board |
John D. Pavlidis | - | 2015 | Independent Non-Executive Director |
Kiyoshi Namba | - | - | Member of Medical Advisory Board |
Ann Custin | 63 | 2021 | Independent Non-Executive Director |
Bruce F. Schroeder | - | - | Member of Medical Advisory Board |
Karin Lindgren | - | 2020 | Independent Non-Executive Director |
Nico Karssemeijer | - | - | Co-Founder & Member of Scientific Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review